Febuxostat tablets recalled due to microbial contamination in manufacturing
Sun Pharmaceutical is recalling 7,488 bottles of Febuxostat 80mg tablets nationwide due to microbial contamination found in manufacturing equipment. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II recall with no reported illnesses or injuries. The microbial contamination was identified in manufacturing equipment rather than in the final product itself, and the recall was initiated as a precautionary measure based on manufacturing deviations.
Plain-English summary
Sun Pharmaceutical Industries Inc. is recalling 7,488 bottles of Febuxostat 80mg tablets (Lot #DNE0894A, expiration 07/31/2025) due to microbial contamination discovered during manufacturing. The contamination was found in stagnant water in a manufacturing equipment duct.
The recalled product was distributed nationwide. Febuxostat is a prescription medication used to treat gout.
The U.S. Food and Drug Administration classified this as a Class II recall. No illnesses or adverse events related to this product have been reported.
The recalled product
- Product
- FEBUXOSTAT (FEBUXOSTAT)
- Brand
- FEBUXOSTAT
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: DNE0894A
- Exp 07/31/2025
UPCs (1)
- 0316714060019
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · FEBUXOSTAT
- HighPrescription drug Febuxostat recalled due to manufacturing contamination
FDA (Drugs) · 2024-03-20
- ModeratePrescription Drug Febuxostat Recalled Due to Manufacturing Practice Violations
FDA (Drugs) · 2024-02-14
- ModerateFebuxostat Prescription Tablets Recalled Nationwide for Manufacturing Contamination
FDA (Drugs) · 2024-01-31
- HighFebuxostat 80 mg prescription tablets recalled for manufacturing contamination
FDA (Drugs) · 2024-01-31
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27